JACC Adv. 2026 Jan 28:102579. doi: 10.1016/j.jacadv.2025.102579. Online ahead of print.ABSTRACTBACKGROUND: Current guidelines recommend discussing patients with infective endocarditis in an endocarditis team (ET). The benefits of an ET have been established, but not the evolution over time.OBJECTIVE
No abstractJACC Cardiovasc Interv. 2026 Jan 19:S1936-8798(25)03403-X. doi: 10.1016/j.jcin.2025.12.010. Online ahead of print.NO ABSTRACTPMID:41609541 | DOI:10.1016/j.jcin.2025.12.010
No abstractJACC Cardiovasc Interv. 2026 Jan 27:S1936-8798(25)03399-0. doi: 10.1016/j.jcin.2025.12.007. Online ahead of print.NO ABSTRACTPMID:41609539 | DOI:10.1016/j.jcin.2025.12.007
JACC Cardiovasc Interv. 2026 Jan 21:S1936-8798(25)03198-X. doi: 10.1016/j.jcin.2025.12.003. Online ahead of print.ABSTRACTBACKGROUND: Right ventricular (RV)-pulmonary arterial (PA) coupling, a measure of RV function in relation to pulmonary afterload, has emerged as a promising prognostic marker in
No abstractJACC Clin Electrophysiol. 2026 Jan 20:S2405-500X(25)01020-5. doi: 10.1016/j.jacep.2025.12.007. Online ahead of print.NO ABSTRACTPMID:41609531 | DOI:10.1016/j.jacep.2025.12.007
J Physiol. 2026 Jan 29. doi: 10.1113/JP288949. Online ahead of print.ABSTRACTGlyH-101 is a commonly used pore blocker of the cystic fibrosis transmembrane conductance regulator (CFTR) to confirm the functional role of CFTR in model systems. Unlike most other anionic CFTR blockers GlyH-101 blocks CFT
Eur Heart J. 2026 Jan 29:ehaf1066. doi: 10.1093/eurheartj/ehaf1066. Online ahead of print.ABSTRACTBACKGROUND AND AIMS: Glucagon-like peptide-1 receptor agonists reduce heart failure (HF) risk in patients with diabetes or obesity. However, the extent to which this reduced risk is dependent on, or ext
Int J Dermatol. 2026 Jan 29. doi: 10.1111/ijd.70306. Online ahead of print.ABSTRACTBACKGROUND: Psoriasis is a chronic immune-mediated disease associated with multiple systemic comorbidities. Biologic therapies have transformed the management of moderate-to-severe psoriasis; however, their high cost
J Am Nutr Assoc. 2026 Jan 29:1-13. doi: 10.1080/27697061.2025.2610805. Online ahead of print.ABSTRACTOBJECTIVE: Recent evidence suggests that gut microbial imbalance may contribute to the pathogenesis of obesity-related metabolic disorders, including cardiovascular diseases. Although the underlying
J Am Nutr Assoc. 2026 Jan 29:1-15. doi: 10.1080/27697061.2025.2588435. Online ahead of print.ABSTRACTOBJECTIVES: Understanding the biological pathways linking low-carbohydrate diets (LCDs) to cardiovascular diseases (CVDs) is complex due to heterogeneity in LCD patterns, limited clinical biomarkers
Adv Sci (Weinh). 2026 Jan 29:e17126. doi: 10.1002/advs.202517126. Online ahead of print.ABSTRACTHepatocyte transplantation effectively treats liver failure, yet the regenerative mechanisms driven by engrafted mature hepatocytes remain elusive. Through integrated serial transplantation, lineage traci
Radiol Cardiothorac Imaging. 2026 Feb;8(1):e250205. doi: 10.1148/ryct.250205.ABSTRACTPurpose To evaluate the predictive value of myosteatosis as an opportunistic finding in coronary artery calcium (CAC) CT scans for clinically diagnosed chronic obstructive pulmonary disease (COPD) and compare it wit
Hepatol Res. 2026 Jan 29. doi: 10.1111/hepr.70133. Online ahead of print.ABSTRACTAIM: Fontan surgery improves outcomes in univentricular heart disease; however, some patients develop severe Fontan-associated liver disease (FALD). Even during adolescence, hepatocellular carcinoma occurs in some patie
FASEB J. 2026 Feb 15;40(3):e71481. doi: 10.1096/fj.202500863RRRR.ABSTRACTThere is ample evidence that exercise contributes to prevention and treatment of myocardial infarction. Although transmembrane protein fibronectin type III domain protein 5 (FNDC5)/Irisin is known to mediate the protective effe
Health Educ Res. 2026 Jan 9;41(1):cyaf059. doi: 10.1093/her/cyaf059.ABSTRACTPatients with multiple myeloma (MM) experience various symptoms throughout their treatment and have psychosocial needs that must be addressed. This study aims to develop and evaluate a psychoeducation program for MM patients
Age Ageing. 2026 Jan 3;55(1):afag003. doi: 10.1093/ageing/afag003.ABSTRACTOBJECTIVE: Patients with chronic limb-threatening ischaemia (CLTI) are often admitted emergently with significant comorbidity and frailty, and little time for pre-optimisation, resulting in longer hospital stays and worse outc
Age Ageing. 2026 Jan 3;55(1):afag006. doi: 10.1093/ageing/afag006.ABSTRACTINTRODUCTION: High blood pressure (BP), functional decline, and cognitive decline commonly co-occur in late life. The temporal dynamics between changes in BP and changes in functional or cognitive status remain unclear. The ai
Age Ageing. 2026 Jan 3;55(1):afag005. doi: 10.1093/ageing/afag005.ABSTRACTBACKGROUND: Orthostatic hypotension (OH) increases the risk of dementia. Although intensive blood pressure (BP) lowering may have cognitive benefits regardless of baseline OH status, its effects in participants who develop OH
No abstractCardiovasc Res. 2026 Jan 29:cvag037. doi: 10.1093/cvr/cvag037. Online ahead of print.NO ABSTRACTPMID:41609295 | DOI:10.1093/cvr/cvag037
JACC Adv. 2026 Jan;5(1):102465. doi: 10.1016/j.jacadv.2025.102465.ABSTRACTIt has long been acknowledged that the risk of cardiovascular disease is impacted by a complex interplay between the heart and kidneys. The relationship among cardiovascular disease, chronic kidney disease, and metabolic disea
No abstractJACC Adv. 2026 Jan;5(1):102500. doi: 10.1016/j.jacadv.2025.102500.NO ABSTRACTPMID:41609288 | DOI:10.1016/j.jacadv.2025.102500
JACC Adv. 2026 Jan;5(1):102476. doi: 10.1016/j.jacadv.2025.102476.ABSTRACTHeart failure with mildly reduced ejection fraction (HFmrEF) is increasingly recognized as a distinct yet heterogeneous phenotype within the heart failure spectrum. Advances in diagnostic tools, including strain imaging, cardi
JACC Adv. 2026 Jan;5(1):102478. doi: 10.1016/j.jacadv.2025.102478.ABSTRACTBACKGROUND: The Ross procedure, involving pulmonary autograft replacement of the aortic valve, has remained underutilized. Recent technical advancements have prompted renewed interest in the Ross operation, particularly as an
JACC Adv. 2026 Jan;5(1):102483. doi: 10.1016/j.jacadv.2025.102483.ABSTRACTBACKGROUND: Childhood maltreatment (CM) may increase cardiovascular disease (CVD) risk through behavioral and health pathways; while maintaining cardiovascular health, Life's Essential 8 (LE8) may modify this association.OBJEC
